Fibrin-stabilizing factor inhibitors. 1972

J L Nilsson, and P Stenberg, and C Ljunggren, and K J Hoffman, and R Lundén, and O Eriksson, and L Lorand

UI MeSH Term Description Entries
D008744 Methylamines Derivatives of methylamine (the structural formula CH3NH2).
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D002103 Cadaverine A foul-smelling diamine formed by bacterial DECARBOXYLATION of LYSINE. It is also an intermediate secondary metabolite in lysine-derived alkaloid biosynthetic pathways (e.g., QUINOLIZIDINES and LYCOPODIUM). 1,5-Pentanediamine,BioDex 1,Pentamethylenediamine,1,5 Pentanediamine
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003509 Cyclohexanecarboxylic Acids Carboxylic acid derivatives of cyclohexane. Acids, Cyclohexanecarboxylic
D003619 Dansyl Compounds Compounds that contain a 1-dimethylaminonaphthalene-5-sulfonyl group. Dimethylaminonaphthalenesulfonyl Compounds,Compounds, Dansyl,Compounds, Dimethylaminonaphthalenesulfonyl
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005176 Factor XIII A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. Coagulation Factor XIII,Factor XIII Transamidase,Fibrin Stabilizing Factor,Fibrinase,Laki-Lorand Factor,Blood Coagulation Factor XIII,Factor 13,Factor Thirteen,Laki Lorand Factor,Factor XIII, Coagulation,Stabilizing Factor, Fibrin,Transamidase, Factor XIII,XIII, Coagulation Factor

Related Publications

J L Nilsson, and P Stenberg, and C Ljunggren, and K J Hoffman, and R Lundén, and O Eriksson, and L Lorand
January 2007, Izvestiia Akademii nauk. Seriia biologicheskaia,
J L Nilsson, and P Stenberg, and C Ljunggren, and K J Hoffman, and R Lundén, and O Eriksson, and L Lorand
December 1970, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
J L Nilsson, and P Stenberg, and C Ljunggren, and K J Hoffman, and R Lundén, and O Eriksson, and L Lorand
October 1970, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
J L Nilsson, and P Stenberg, and C Ljunggren, and K J Hoffman, and R Lundén, and O Eriksson, and L Lorand
January 1981, Methods in enzymology,
J L Nilsson, and P Stenberg, and C Ljunggren, and K J Hoffman, and R Lundén, and O Eriksson, and L Lorand
January 1968, The American journal of medicine,
J L Nilsson, and P Stenberg, and C Ljunggren, and K J Hoffman, and R Lundén, and O Eriksson, and L Lorand
January 1976, Methods in enzymology,
J L Nilsson, and P Stenberg, and C Ljunggren, and K J Hoffman, and R Lundén, and O Eriksson, and L Lorand
June 1968, Il Policlinico. Sezione pratica,
J L Nilsson, and P Stenberg, and C Ljunggren, and K J Hoffman, and R Lundén, and O Eriksson, and L Lorand
October 1964, Ugeskrift for laeger,
J L Nilsson, and P Stenberg, and C Ljunggren, and K J Hoffman, and R Lundén, and O Eriksson, and L Lorand
January 1980, Progress in hemostasis and thrombosis,
J L Nilsson, and P Stenberg, and C Ljunggren, and K J Hoffman, and R Lundén, and O Eriksson, and L Lorand
October 2008, Hawaii medical journal,
Copied contents to your clipboard!